Important Safety Considerations Semaglutide is not recommended for those with (Kommu & Whitfield, 2024) : Personal/family history of medullary thyroid carcinoma MEN2 Previous pancreatitis It can also increase the risk of hypoglycemia when used with insulin or sulfonylureas(Kommu & Whitfield, 2024)
Patients should not discontinue or alter thyroid hormone replacement when using tirzepatide, and close endocrinologic supervision remains essential
Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants
Ive joined your rss feed and sit up for searching for more of your magnificent post
It means you need to understand the actual pathways that exist, what they require, and what approved alternatives are producing real results right now
Mounjaro has a pretty long half-life, which is why you only have to inject it once a week